SUMMARY: CDG-1a is an early-onset neurodegenerative disease with selective hindbrain involvement and highly variable clinical presentation. We retrospectively reviewed the clinical records and MR imaging studies of 5 children (3 boys and 2 girls aged 12 days to 2 years at presentation) with molecularly confirmed CDG-1a. The cerebellum was hypoplastic at presentation in 4 cases, progressive bulk loss involved the cerebellum and the pons in all cases, and the cerebellar cortex and subcortical white matter were hyperintense on T2-weighted and FLAIR images in all. We conclude that CDG-1a likely results from a combination of cerebellar hypoplasia and atrophy. Cerebellar volume loss with diffuse T2/FLAIR hyperintensity seems to be a peculiar association in the field of cerebellar atrophies, and may be useful to address the differential diagnosis.ABBREVIATIONS: BAEP ϭ brain stem auditory evoked potential; CA ϭ cerebellar atrophy; CDG ϭ congenital disorders of glycosylation; CH ϭ cerebellar hypoplasia; EEG ϭ electroencephalogram; ERG ϭ electroretinogram; mIns ϭ myo-inositol; NCV ϭ nerve conduction velocity; PMM ϭ phosphomannomutase; PRESS ϭ point-resolved spectroscopy sequence; sI ϭ scyllo-inositol; VEP ϭ visual-evoked potentials C DGs are genetically heterogeneous autosomal recessive disorders caused by abnormal glycosylation of N-linked oligosaccharides. CDG-1a (OMIM#212065), caused by mutation in the gene encoding PMM2, is the most common form. The clinical presentation and course are highly variable, ranging from severe infantile multisystem involvement to mild late-onset forms.1 Muscular hypotonia, strabismus, and developmental delay are variably associated with dysmorphic features, abnormal subcutaneous fat distribution ("fat pads"), nipple retraction, feeding problems, and failure to thrive. Stroke-like episodes have also been reported.3 Brain MR imaging studies have consistently shown a small cerebellum, variably designated as cerebellar hypoplasia, olivopontocerebellar hypoplasia, or cerebellar atrophy.3-7 The purpose of this study is to describe the MR imaging findings on initial and follow-up studies in patients with CDG-1a and to identify suggestive MR imaging features that may prompt further diagnostic tests.
Materials and MethodsInstitutional review board approval was not sought, as it is not required in our country for retrospective studies that do not involve patient identity disclosure. Five Italian children (3 males and 2 females, aged 12 days to 2 years at clinical presentation) with confirmed CDG-1a constitute the focus of this article. These patients were selected on the basis of a molecular genetic confirmation of the diagnosis and the availability of at least 1 MR imaging study for evaluation. We retrospectively reviewed their clinical, laboratory, electrophysiologic, and neurologic information. Laboratory investigations included routine blood work, analysis of transferrin by serum isoelectric focusing, and enzymatic analysis of PMM activity on skin fibroblasts. In all cases, molecular analysis of...